The global graft versus host disease treatment market is on a strong growth trajectory, with an estimated valuation of USD 2,713.6 million in 2023. According to recent projections, the market is expected to expand at a robust Compound Annual Growth Rate (CAGR) of 8.2%, reaching approximately USD 5,960.7 million by 2033. GvHD, a serious complication …